EG18523A - Substained release matrix formulations - Google Patents

Substained release matrix formulations

Info

Publication number
EG18523A
EG18523A EG109/88A EG10988A EG18523A EG 18523 A EG18523 A EG 18523A EG 109/88 A EG109/88 A EG 109/88A EG 10988 A EG10988 A EG 10988A EG 18523 A EG18523 A EG 18523A
Authority
EG
Egypt
Prior art keywords
release matrix
matrix formulations
substained release
substained
formulations
Prior art date
Application number
EG109/88A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of EG18523A publication Critical patent/EG18523A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
EG109/88A 1987-02-27 1988-02-25 Substained release matrix formulations EG18523A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1991587A 1987-02-27 1987-02-27

Publications (1)

Publication Number Publication Date
EG18523A true EG18523A (en) 1993-04-30

Family

ID=21795732

Family Applications (1)

Application Number Title Priority Date Filing Date
EG109/88A EG18523A (en) 1987-02-27 1988-02-25 Substained release matrix formulations

Country Status (26)

Country Link
EP (1) EP0280571B1 (cs)
JP (1) JPH082793B2 (cs)
KR (1) KR960005140B1 (cs)
CN (1) CN1023765C (cs)
AR (1) AR243376A1 (cs)
AT (1) ATE92309T1 (cs)
AU (1) AU604849B2 (cs)
CA (1) CA1316110C (cs)
CY (1) CY1741A (cs)
DE (2) DE280571T1 (cs)
DK (1) DK175620B1 (cs)
EG (1) EG18523A (cs)
ES (1) ES2044825T3 (cs)
GR (1) GR930300027T1 (cs)
HK (1) HK125793A (cs)
HU (1) HU202747B (cs)
IE (1) IE61419B1 (cs)
IL (1) IL85538A (cs)
LV (1) LV10184B (cs)
MX (1) MX10558A (cs)
NZ (1) NZ223619A (cs)
PH (1) PH24358A (cs)
PT (1) PT86831B (cs)
RU (1) RU1831337C (cs)
UA (1) UA18251A (cs)
ZA (1) ZA881301B (cs)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
AU660147B2 (en) * 1990-05-04 1995-06-15 Perio Products Ltd. Colonic drug delivery system
FR2667242B1 (fr) * 1990-09-28 1994-11-25 Rhone Poulenc Sante Nouvelles formes orales a liberation prolongee avec un temps de latence au niveau stomacal amoindri.
IT1250654B (it) * 1991-07-08 1995-04-21 Farcon Ag Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
CA2174538A1 (en) * 1993-10-22 1995-04-27 Michio Nagasawa Base for sustained-release preparation, sustained-release preparation, and process for producing the preparation
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
PT906089E (pt) 1996-05-13 2004-01-30 Novartis Consumer Health Sa Sistema de administracao bucal
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
AU3277899A (en) * 1998-03-03 1999-09-20 Dae Woong Chemical Co., Ltd. Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption
KR100296413B1 (ko) * 1998-04-01 2001-11-14 김선진 세파클러함유서방성정제
AT413647B (de) 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
DE60039377D1 (de) 1999-02-09 2008-08-21 Pfizer Prod Inc Zusammensetzungen basischer Arzneistoffe mit verbesserter Bioverfügbarkeit
KR100647901B1 (ko) * 1999-07-09 2006-11-17 보령제약 주식회사 세파클러-함유 서방성 약제조성물 및 그의 제조방법
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
WO2001048303A2 (en) 1999-12-28 2001-07-05 Kimberly-Clark Worldwide, Inc. A wiper containing a controlled-release anti-microbial agent
DE60034368T2 (de) 1999-12-28 2008-01-03 Kimberly-Clark Worldwide, Inc., Neenah Verwendungs-abhängiges indikatorsystem für absorbierende artikel
BR0016015B1 (pt) 1999-12-28 2010-12-28 pano de limpeza para desinfetar superfìcies rìgidas e método de formação de um pano de limpeza antimicrobiano para desinfetar superfìcie rìgidas.
US6372252B1 (en) * 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
WO2002036126A1 (en) * 2000-10-30 2002-05-10 Lupin Limited Rapidly disintegrating sustained release cefuroxime axetil composition
ES2645930T3 (es) * 2003-01-03 2017-12-11 Supernus Pharmaceuticals, Inc. Utilización de una mezcla de dos o más materiales entéricos para regular la liberación de fármacos a través de una membrana o matriz para terapias sistémicas
DE102005019458A1 (de) * 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
EP1837020A1 (en) * 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
JP5253381B2 (ja) 2006-04-26 2013-07-31 スパーナス ファーマシューティカルズ インコーポレイテッド シグモイド放出プロファイルを有するオキサカルバゼピンの制御放出製剤
WO2008059792A1 (fr) * 2006-11-13 2008-05-22 Kyorin Pharmaceutical Co., Ltd. Procédé de production d'un comprimé à libération prolongée
RU2011142829A (ru) 2009-03-27 2013-05-10 Киорин Фармасьютикал Ко., Лтд. Препарат матричного типа с пролонгированным высвобождением, содержащий базисную добавку
US20120039999A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
CN101912373B (zh) * 2010-08-24 2012-01-04 北京京丰制药有限公司 稳定的头孢克洛分散片及其制备方法
CN106456681B (zh) * 2014-06-10 2019-11-22 狮王株式会社 含有清酒酵母的片剂
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151913B (cs) * 1980-01-11 1983-09-03 Boots Co Ltd
JPS6024765B2 (ja) * 1981-11-27 1985-06-14 辰巳化学株式会社 セフアレキシンの持続性製剤の製造方法
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
JPS61286330A (ja) * 1985-06-11 1986-12-16 Teijin Ltd 経口徐放性製剤
JPS62120315A (ja) * 1985-11-20 1987-06-01 Shin Etsu Chem Co Ltd 経口投与型徐放性錠剤の製造方法

Also Published As

Publication number Publication date
HK125793A (en) 1993-11-19
NZ223619A (en) 1990-10-26
DE280571T1 (de) 1993-08-12
EP0280571A2 (en) 1988-08-31
DE3882739T2 (de) 1994-02-17
AR243376A1 (es) 1993-08-31
ES2044825T1 (es) 1994-01-16
AU604849B2 (en) 1991-01-03
ZA881301B (en) 1989-10-25
CA1316110C (en) 1993-04-13
CY1741A (en) 1995-02-17
DE3882739D1 (de) 1993-09-16
AU1219388A (en) 1988-09-01
ATE92309T1 (de) 1993-08-15
HUT46531A (en) 1988-11-28
ES2044825T3 (es) 1994-11-16
IE880545L (en) 1988-08-27
CN1023765C (zh) 1994-02-16
PT86831A (pt) 1988-03-01
DK175620B1 (da) 2004-12-27
EP0280571A3 (en) 1989-01-04
UA18251A (uk) 1997-12-25
EP0280571B1 (en) 1993-08-04
IL85538A0 (en) 1988-08-31
PT86831B (pt) 1992-05-29
HU202747B (en) 1991-04-29
KR880009639A (ko) 1988-10-04
GR930300027T1 (cs) 1993-05-24
LV10184A (lv) 1994-10-20
RU1831337C (ru) 1993-07-30
CN88101062A (zh) 1988-09-07
IL85538A (en) 1991-09-16
JPH082793B2 (ja) 1996-01-17
DK98088D0 (da) 1988-02-25
PH24358A (en) 1990-06-13
DK98088A (da) 1988-08-28
JPS63227519A (ja) 1988-09-21
KR960005140B1 (ko) 1996-04-22
IE61419B1 (en) 1994-11-02
MX10558A (es) 1993-11-01
LV10184B (en) 1995-04-20

Similar Documents

Publication Publication Date Title
EG18523A (en) Substained release matrix formulations
EP0306236A3 (en) Controlled release formulations
GB2207353B (en) Controlled release formulation
AR243378A1 (es) Procedimiento para preparar una formulacion farmaceutica de liberacion prolongada.
NZ225402A (en) Oral sustained release acetaminophen formulations
ZA878499B (en) Transdermal contraceptive formulations
EP0318899A3 (en) Release agent composition
GB8715436D0 (en) Substituted anthraquinones
JPS6490279A (en) Silicone release
AU7942087A (en) Sustained release formulations
IL88148A0 (en) Somatotropin sustained release formulations
GB8521221D0 (en) Controlled release formulations
ZA896012B (en) Controlled release formulations
IE871503L (en) Sustained release formulations
AU589254C (en) Slow release formulations
GB8922061D0 (en) Controlled release formulations
GB8729673D0 (en) Formulations
SG27194G (en) Sustained release etodaloc
GB8716488D0 (en) Release mechanism
ZA881843B (en) Somatotropin prolonged release
IE862339L (en) Disc-like sustained release formulations
IE850071L (en) Controlled release pharmaceutical formulations
GB8705453D0 (en) Insecticidal formulations
IE872675L (en) Sustained release pharmaceutical
GB8704774D0 (en) Pharmaceutical formulations